Genmab（GMAB）股价上涨13.16%，此前这家丹麦生物技术公司表示，在一项后期临床试验中，一种实验性药物降低了卵巢癌患者的死亡和疾病进展风险。
Genmab GMAB 13.16%increase; up pointing triangle shares climbed after the Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial.
周一欧洲早盘交易中，Genmab股价上涨13%，使其今年迄今涨幅接近48%。
Shares in Genmab were up 13% in European morning trade Monday, lifting their year-to-date gain to nearly 48%.